mirtazapine has been researched along with Encephalitis, JC Polyomavirus in 49 studies
Mirtazapine: A piperazinoazepine tetracyclic compound that enhances the release of NOREPINEPHRINE and SEROTONIN through blockage of presynaptic ALPHA-2 ADRENERGIC RECEPTORS. It also blocks both 5-HT2 and 5-HT3 serotonin receptors and is a potent HISTAMINE H1 RECEPTOR antagonist. It is used for the treatment of depression, and may also be useful for the treatment of anxiety disorders.
| Excerpt | Relevance | Reference |
|---|---|---|
| "An 83-year-old man presented with visual disturbance and right hemiparalysis, one month after daratumumab, bortezomib, and dexamethasone administration for multiple myeloma (MM)." | 8.31 | [A case of progressive multifocal leukoencephalopathy associated with daratumumab, bortezomib, and dexamethasone for multiple myeloma]. ( Enomoto, S; Hamano, T; Kitazaki, Y; Morita, M; Nakamichi, K; Usui, K, 2023) |
| "Demonstration of survival and outcome of progressive multifocal leukoencephalopathy (PML) in a 56-year-old patient with common variable immunodeficiency, consisting of severe hypogammaglobulinemia and CD4+ T lymphocytopenia, during continuous treatment with mirtazapine (30 mg/day) and mefloquine (250 mg/week) over 23 months." | 7.81 | Progressive multifocal leukoencephalopathy in common variable immunodeficiency: mitigated course under mirtazapine and mefloquine. ( Bassetti, CL; Du Pasquier, R; Furrer, H; Hirsch, HH; Kardas, P; Krestel, H; Kurmann, R; Lämmle, B; Sturzenegger, M; Weisstanner, C; Wiest, R, 2015) |
| "Mirtazapine 15 mg was started while prednisone treatment was continued." | 5.43 | Clearance of cerebrospinal fluid JCV DNA with mirtazapine in a patient with progressive multifocal leukoencephalopathy and sarcoidosis. ( Atzori, C; Bonora, S; Busolli, P; Calcagno, A; Ghisetti, V; Imperiale, D; Trentalange, A, 2016) |
| "An 83-year-old man presented with visual disturbance and right hemiparalysis, one month after daratumumab, bortezomib, and dexamethasone administration for multiple myeloma (MM)." | 4.31 | [A case of progressive multifocal leukoencephalopathy associated with daratumumab, bortezomib, and dexamethasone for multiple myeloma]. ( Enomoto, S; Hamano, T; Kitazaki, Y; Morita, M; Nakamichi, K; Usui, K, 2023) |
| "Demonstration of survival and outcome of progressive multifocal leukoencephalopathy (PML) in a 56-year-old patient with common variable immunodeficiency, consisting of severe hypogammaglobulinemia and CD4+ T lymphocytopenia, during continuous treatment with mirtazapine (30 mg/day) and mefloquine (250 mg/week) over 23 months." | 3.81 | Progressive multifocal leukoencephalopathy in common variable immunodeficiency: mitigated course under mirtazapine and mefloquine. ( Bassetti, CL; Du Pasquier, R; Furrer, H; Hirsch, HH; Kardas, P; Krestel, H; Kurmann, R; Lämmle, B; Sturzenegger, M; Weisstanner, C; Wiest, R, 2015) |
| "Mirtazapine use was safe and well tolerated." | 2.74 | Mirtazapine use in human immunodeficiency virus-infected patients with progressive multifocal leukoencephalopathy. ( Cettomai, D; McArthur, JC, 2009) |
| "We report a 68-year-old man with systemic lupus erythematosus under treatment with immunosuppressants who developed non-HIV PML with brain lesions limited to the cerebellum and brainstem and successfully treated with a combination of mefloquine and mirtazapine." | 2.66 | Successful treatment of non-HIV progressive multifocal leukoencephalopathy: case report and literature review. ( Arai, S; Fujita, H; Hamaguchi, M; Hirata, K; Kikuchi, S; Matsuda, H; Nakamichi, K; Nakamura, T; Saijo, M; Shishido-Hara, Y; Suzuki, K; Uzuka, T, 2020) |
| "Mirtazapine was commenced based on case reports of successful use in non-transplant patients; the patient's recovery was temporally related to withdrawal of immunosuppression and increasing mirtazapine dosage." | 1.72 | Progressive multifocal leukoencephalopathy 10 years following transplant: 5HT receptor antagonism as an adjunct to immune reconstitution. ( Chandler, S; Isbel, N, 2022) |
| "Treatment with mirtazapine, mefloquine and cidofovir did not affect the progression of the disease, which was fatal within 7 months of presentation." | 1.48 | Progressive multifocal leukoencephalopathy in the absence of immunosuppression. ( Stacpoole, SRL; Zucker, BE, 2018) |
| "Steroids were restarted and his ataxia stabilized." | 1.46 | JC virus granule cell neuronopathy in the setting of chronic lymphopenia treated with recombinant interleukin-7. ( Angeles, MR; Bucelli, RC; Clifford, DB; Dang, X; Koralnik, IJ; Kuhlmann, FM; Major, EO; Ryschkewitsch, CF; Schmidt, RE; Schwetye, KE; Soleimani-Meigooni, DN, 2017) |
| "Mirtazapine 15 mg was started while prednisone treatment was continued." | 1.43 | Clearance of cerebrospinal fluid JCV DNA with mirtazapine in a patient with progressive multifocal leukoencephalopathy and sarcoidosis. ( Atzori, C; Bonora, S; Busolli, P; Calcagno, A; Ghisetti, V; Imperiale, D; Trentalange, A, 2016) |
| "An 83-year-old man with chronic renal failure was referred to our hospital because of subacute progressive right hemiparesis." | 1.43 | A case of progressive multifocal leukoencephalopathy with chronic renal failure, whose JC virus in cerebrospinal fluid disappeared after mefloquine-mirtazapine dual therapy. ( Asayama, S; Asayama, T; Kosaka, S; Nakamichi, K; Ohnuki, E; Saijo, M, 2016) |
| "Treatment with mirtazapine 30 mg orally daily and mefloquine hydrochloride 250 mg orally for three days, then 250 mg weekly, was initiated." | 1.38 | Mirtazapine and mefloquine therapy for progressive multifocal leukoencephalopathy in a patient infected with human immunodeficiency virus. ( Jett, RA; Moenster, RP, 2012) |
| "A patient with multiple myeloma was treated with high-dose chemotherapy followed by two autologous bone marrow transplantations (ABMTs)." | 1.37 | Progressive multifocal leucoencephalopathy after autologous bone marrow transplantation: a treatment option. ( Brustia, D; Cantello, R; Comi, C; Conconi, A; De Paoli, L; Gaidano, G; Monaco, F; Mula, M; Nasuelli, N; Ripellino, P; Savio, K; Stecco, A; Varrasi, C, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (14.29) | 29.6817 |
| 2010's | 34 (69.39) | 24.3611 |
| 2020's | 8 (16.33) | 2.80 |
| Authors | Studies |
|---|---|
| Sriwastava, S | 1 |
| Khan, E | 1 |
| Khalid, SH | 1 |
| Kaur, A | 1 |
| Feizi, P | 1 |
| Wang, W | 1 |
| Yang, H | 1 |
| Piao, Y | 1 |
| Quan, M | 1 |
| Guo, D | 1 |
| Wang, X | 2 |
| Chen, J | 2 |
| Gong, J | 2 |
| Wu, Y | 2 |
| Liu, XH | 2 |
| Chandler, S | 2 |
| Isbel, N | 2 |
| Cifci, B | 1 |
| Yildiz, Y | 1 |
| Altin, E | 1 |
| Habibi, H | 1 |
| Kocer, B | 1 |
| Dizbay, M | 1 |
| Usui, K | 1 |
| Kitazaki, Y | 1 |
| Enomoto, S | 1 |
| Morita, M | 1 |
| Nakamichi, K | 8 |
| Hamano, T | 1 |
| Hamaguchi, M | 1 |
| Suzuki, K | 1 |
| Fujita, H | 1 |
| Uzuka, T | 1 |
| Matsuda, H | 1 |
| Shishido-Hara, Y | 3 |
| Arai, S | 1 |
| Nakamura, T | 1 |
| Kikuchi, S | 1 |
| Saijo, M | 5 |
| Hirata, K | 1 |
| Quiñones-Aguilar, S | 1 |
| Sauri-Suárez, S | 1 |
| Alcaraz-Estrada, SL | 1 |
| García, S | 1 |
| Maréchal, E | 1 |
| Beel, K | 1 |
| Crols, R | 1 |
| Hernalsteen, D | 1 |
| Willekens, B | 1 |
| Ikeda, J | 2 |
| Matsushima, A | 1 |
| Ishii, W | 2 |
| Goto, T | 1 |
| Takahashi, K | 1 |
| Sekijima, Y | 2 |
| Ikeda, SI | 1 |
| Scholten, P | 1 |
| Kralt, P | 1 |
| Jacobs, B | 1 |
| Zucker, BE | 1 |
| Stacpoole, SRL | 1 |
| Akagawa, Y | 1 |
| Ueno, A | 1 |
| Scabini, S | 1 |
| Trunfio, M | 1 |
| Pirriatore, V | 1 |
| Imperiale, D | 2 |
| Audagnotto, S | 1 |
| Bertucci, R | 1 |
| Ghisetti, V | 2 |
| Cinnirella, G | 1 |
| Cistaro, A | 1 |
| Perna, M | 1 |
| Calcagno, A | 2 |
| Di Perri, G | 1 |
| Kano, Y | 1 |
| Inoue, H | 1 |
| Sakurai, K | 1 |
| Yoshida, M | 1 |
| Miura, Y | 1 |
| Yuasa, H | 1 |
| Aung, AK | 1 |
| Robinson, J | 1 |
| Hey, P | 1 |
| Lehmann, M | 1 |
| Chow, Y | 1 |
| Stark, RJ | 1 |
| Bosco, JJ | 1 |
| Peña, M | 1 |
| Presas-Rodríguez, S | 1 |
| Ribera, JM | 1 |
| Takekoshi, A | 1 |
| Yoshikura, N | 1 |
| Ozawa, K | 1 |
| Ikoma, Y | 1 |
| Kitagawa, J | 1 |
| Takeshima, A | 1 |
| Otsuki, M | 1 |
| Ohe, N | 1 |
| Mochizuki, K | 1 |
| Kakita, A | 1 |
| Shimohata, T | 1 |
| Nishigori, R | 1 |
| Warabi, Y | 1 |
| Nakata, Y | 1 |
| Komori, T | 1 |
| Isozaki, E | 1 |
| Loyaga-Rendon, RY | 1 |
| Taylor, DO | 1 |
| Koval, CE | 1 |
| Iannetta, M | 1 |
| Bellizzi, A | 1 |
| Lo Menzo, S | 1 |
| Anzivino, E | 1 |
| D'Abramo, A | 1 |
| Oliva, A | 1 |
| D'Agostino, C | 1 |
| d'Ettorre, G | 1 |
| Pietropaolo, V | 1 |
| Vullo, V | 1 |
| Ciardi, MR | 1 |
| Yoshida, H | 1 |
| Ohshima, K | 1 |
| Toda, J | 1 |
| Kusakabe, S | 1 |
| Masaie, H | 1 |
| Yagi, T | 1 |
| Ishikawa, J | 1 |
| Di Pauli, F | 1 |
| Berger, T | 1 |
| Walder, A | 1 |
| Maier, H | 1 |
| Rhomberg, P | 1 |
| Uprimny, C | 1 |
| Steurer, M | 1 |
| Stockhammer, G | 1 |
| Meister, S | 1 |
| Benecke, R | 1 |
| König, FB | 1 |
| Großmann, A | 1 |
| Zettl, UK | 1 |
| Winkelmann, A | 1 |
| Epperla, N | 1 |
| Medina-Flores, R | 1 |
| Mazza, JJ | 1 |
| Yale, SH | 1 |
| Kurmann, R | 1 |
| Weisstanner, C | 1 |
| Kardas, P | 1 |
| Hirsch, HH | 1 |
| Wiest, R | 1 |
| Lämmle, B | 1 |
| Furrer, H | 1 |
| Du Pasquier, R | 1 |
| Bassetti, CL | 1 |
| Sturzenegger, M | 1 |
| Krestel, H | 1 |
| Loignon, M | 1 |
| Toma, E | 1 |
| Trentalange, A | 1 |
| Atzori, C | 1 |
| Busolli, P | 1 |
| Bonora, S | 1 |
| Ito, D | 1 |
| Yasui, K | 1 |
| Hasegawa, Y | 1 |
| Katsuno, M | 1 |
| Takahashi, A | 1 |
| Jamilloux, Y | 1 |
| Kerever, S | 1 |
| Ferry, T | 1 |
| Broussolle, C | 1 |
| Honnorat, J | 1 |
| Sève, P | 1 |
| Soleimani-Meigooni, DN | 1 |
| Schwetye, KE | 1 |
| Angeles, MR | 1 |
| Ryschkewitsch, CF | 1 |
| Major, EO | 1 |
| Dang, X | 1 |
| Koralnik, IJ | 4 |
| Schmidt, RE | 1 |
| Clifford, DB | 1 |
| Kuhlmann, FM | 1 |
| Bucelli, RC | 1 |
| Lutz, M | 1 |
| Schulze, AB | 1 |
| Rebber, E | 1 |
| Wiebe, S | 1 |
| Zoubi, T | 1 |
| Grauer, OM | 1 |
| Keßler, T | 1 |
| Kerkhoff, A | 1 |
| Lenz, G | 1 |
| Berdel, WE | 1 |
| Ohnuki, E | 1 |
| Asayama, S | 1 |
| Asayama, T | 1 |
| Kosaka, S | 1 |
| Cettomai, D | 1 |
| McArthur, JC | 1 |
| Lanzafame, M | 1 |
| Ferrari, S | 1 |
| Lattuada, E | 1 |
| Corsini, F | 1 |
| Deganello, R | 1 |
| Vento, S | 1 |
| Concia, E | 1 |
| Rock, C | 1 |
| Bergin, C | 1 |
| Fernández-Ruiz, M | 1 |
| de la Serna, J | 1 |
| Ruiz, J | 1 |
| López-Medrano, F | 1 |
| McGuire, JL | 1 |
| Fridman, V | 1 |
| Wüthrich, C | 1 |
| Jacobs, D | 1 |
| Pallin, M | 1 |
| O'Sullivan, C | 1 |
| Dodd, JD | 1 |
| McCreery, K | 1 |
| Brett, F | 1 |
| Farrell, M | 1 |
| O'Brien, D | 1 |
| Hall, WW | 1 |
| Tubridy, NJ | 1 |
| Keane, MP | 1 |
| Damasceno, A | 1 |
| von Glehn, F | 1 |
| Martinez, AR | 1 |
| Longhini, AL | 1 |
| Deus-Silva, L | 1 |
| Brandão, CO | 1 |
| Santos, LM | 1 |
| Damasceno, BP | 1 |
| Moenster, RP | 1 |
| Jett, RA | 1 |
| Rath, T | 1 |
| Hackenbroch, M | 1 |
| Saech, J | 1 |
| Hallek, M | 2 |
| Rubbert, A | 2 |
| Lasso, M | 1 |
| Cerón, I | 1 |
| Ripellino, P | 1 |
| Comi, C | 1 |
| Mula, M | 1 |
| Varrasi, C | 1 |
| Conconi, A | 1 |
| Stecco, A | 1 |
| Brustia, D | 1 |
| Nasuelli, N | 1 |
| Savio, K | 1 |
| De Paoli, L | 1 |
| Cantello, R | 1 |
| Gaidano, G | 1 |
| Monaco, F | 1 |
| Hohlfeld, SK | 1 |
| Günthard, HF | 1 |
| Zeitz, J | 1 |
| Locher, P | 1 |
| Bachli, E | 1 |
| Vulliemoz, S | 1 |
| Lurati-Ruiz, F | 1 |
| Borruat, FX | 1 |
| Delavelle, J | 1 |
| Kuntzer, T | 1 |
| Bogousslavsky, J | 1 |
| Picard, F | 1 |
| Landis, T | 1 |
| Du Pasquier, RA | 1 |
| Owczarczyk, K | 1 |
| Hilker, R | 1 |
| Brunn, A | 1 |
| Verma, S | 1 |
| Cikurel, K | 1 |
| Morgello, S | 1 |
| Cunningham-Rundles, C | 1 |
| Weinstein, ZR | 1 |
| Bergmann, C | 1 |
| Simpson, DM | 1 |
| Focosi, D | 1 |
| Kast, RE | 1 |
| Maggi, F | 1 |
| Lauria, G | 1 |
| Ceccherini-Nelli, L | 1 |
| Petrini, M | 1 |
7 reviews available for mirtazapine and Encephalitis, JC Polyomavirus
| Article | Year |
|---|---|
Progressive multifocal leukoencephalopathy in an immunocompetent patient: A case report and review of literature.
Topics: Brain; Humans; JC Virus; Leukoencephalopathy, Progressive Multifocal; Magnetic Resonance Imaging; Ma | 2022 |
Successful treatment of non-HIV progressive multifocal leukoencephalopathy: case report and literature review.
Topics: Aged; Antidepressive Agents; Antimalarials; Brain Stem; Cerebellum; Humans; Immunocompromised Host; | 2020 |
Long-Term Survival after Progressive Multifocal Leukoencephalopathy in a Patient with Primary Immune Deficiency and NFKB1 Mutation.
Topics: Disease Management; Disease Susceptibility; Genetic Predisposition to Disease; Humans; Leukoencephal | 2020 |
[Idiopathic CD4-positive lymphocytopenia-associated progressive multifocal leukoencephalopathy confirmed by brain biopsy following negative results of repeated CSF-JC-virus tests: a case report].
Topics: Aged; Brain; CD4-Positive T-Lymphocytes; DNA, Viral; Drug Therapy, Combination; Humans; JC Virus; Le | 2018 |
Treatment options for progressive multifocal leukoencephalopathy in HIV-infected persons: current status and future directions.
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Antiviral Agents; Cidofovir; Coinfection; Cy | 2016 |
Treatment of Progressive Multifocal Leukoencephalopathy With Mirtazapine.
Topics: Humans; Immunosuppressive Agents; JC Virus; Leukoencephalopathy, Progressive Multifocal; Mianserin; | 2016 |
[Mirtazapine and antiretroviral therapy in the treatment of progressive multifocal leukoencephalopathy associated with HIV-1 infection: report of a case and review of literature].
Topics: Adult; AIDS Dementia Complex; Antidepressive Agents, Tricyclic; Antiretroviral Therapy, Highly Activ | 2012 |
1 trial available for mirtazapine and Encephalitis, JC Polyomavirus
| Article | Year |
|---|---|
Mirtazapine use in human immunodeficiency virus-infected patients with progressive multifocal leukoencephalopathy.
Topics: Adult; Blood-Brain Barrier; Brain; Drug Administration Schedule; Early Diagnosis; Female; HIV Infect | 2009 |
41 other studies available for mirtazapine and Encephalitis, JC Polyomavirus
| Article | Year |
|---|---|
Progressive multifocal leukoencephalopathy in a patient with mediastinal teratoma: a case report.
Topics: Aged; Brain; Female; Humans; JC Virus; Leukoencephalopathy, Progressive Multifocal; Mirtazapine; Ter | 2022 |
JC virus-induced progressive multifocal leukoencephalopathy in a presumably healthy patient.
Topics: Aged; Brain; Female; Humans; JC Virus; Leukoencephalopathy, Progressive Multifocal; Mefloquine; Mirt | 2022 |
JC virus-induced progressive multifocal leukoencephalopathy in a presumably healthy patient.
Topics: Aged; Brain; Female; Humans; JC Virus; Leukoencephalopathy, Progressive Multifocal; Mefloquine; Mirt | 2022 |
JC virus-induced progressive multifocal leukoencephalopathy in a presumably healthy patient.
Topics: Aged; Brain; Female; Humans; JC Virus; Leukoencephalopathy, Progressive Multifocal; Mefloquine; Mirt | 2022 |
JC virus-induced progressive multifocal leukoencephalopathy in a presumably healthy patient.
Topics: Aged; Brain; Female; Humans; JC Virus; Leukoencephalopathy, Progressive Multifocal; Mefloquine; Mirt | 2022 |
Progressive multifocal leukoencephalopathy 10 years following transplant: 5HT receptor antagonism as an adjunct to immune reconstitution.
Topics: Humans; Immune Reconstitution; Immunosuppressive Agents; JC Virus; Leukoencephalopathy, Progressive | 2022 |
Progressive multifocal leukoencephalopathy 10 years following transplant: 5HT receptor antagonism as an adjunct to immune reconstitution.
Topics: Humans; Immune Reconstitution; Immunosuppressive Agents; JC Virus; Leukoencephalopathy, Progressive | 2022 |
Progressive multifocal leukoencephalopathy 10 years following transplant: 5HT receptor antagonism as an adjunct to immune reconstitution.
Topics: Humans; Immune Reconstitution; Immunosuppressive Agents; JC Virus; Leukoencephalopathy, Progressive | 2022 |
Progressive multifocal leukoencephalopathy 10 years following transplant: 5HT receptor antagonism as an adjunct to immune reconstitution.
Topics: Humans; Immune Reconstitution; Immunosuppressive Agents; JC Virus; Leukoencephalopathy, Progressive | 2022 |
Successful treatment of HIV-associated progressive multifocal leukoencephalopathy (PML) with mirtazapine, mefloquine, and IVIG combination therapy: a case report.
Topics: HIV Infections; Humans; Immunoglobulins, Intravenous; JC Virus; Leukoencephalopathy, Progressive Mul | 2023 |
[A case of progressive multifocal leukoencephalopathy associated with daratumumab, bortezomib, and dexamethasone for multiple myeloma].
Topics: Aged, 80 and over; Bortezomib; Dexamethasone; DNA, Viral; Humans; JC Virus; Leukoencephalopathy, Pro | 2023 |
Progressive Multifocal Leukoencephalopathy associated to treatment with natalizumab in Mexican patient Multiple Sclerosis. Case report, analysis and update.
Topics: Female; Humans; Immunoglobulins; Leukoencephalopathy, Progressive Multifocal; Methylprednisolone; Me | 2019 |
Brain Biopsy Is More Reliable than the DNA test for JC Virus in Cerebrospinal Fluid for the Diagnosis of Progressive Multifocal Leukoencephalopathy.
Topics: Adrenergic alpha-Antagonists; Adult; Antimalarials; Biopsy; Brain; DNA, Viral; Female; Humans; JC Vi | 2017 |
Posterior fossa progressive multifocal leukoencephalopathy: first presentation of an unknown autoimmune disease.
Topics: Adrenergic alpha-Antagonists; Cerebellar Ataxia; Disease Progression; Dysarthria; Fatal Outcome; Hum | 2017 |
Progressive multifocal leukoencephalopathy in the absence of immunosuppression.
Topics: Aged; Alien Limb Phenomenon; Cidofovir; Disease Progression; Fatal Outcome; Female; Humans; Immunoco | 2018 |
[Two patients with progressive multifocal leukoencephalopathy with immune response against JC virus showing good long-term outcome by combination therapy of mefloquine, mirtazapine, and risperidone].
Topics: Adult; Brain; Drug Therapy, Combination; Female; Humans; Immunity, Cellular; JC Virus; Leukoencephal | 2018 |
Antiviral activity of maraviroc plus mirtazapine in a low-risk HIV-negative patient with progressive multifocal leukoencephalopathy.
Topics: CCR5 Receptor Antagonists; Drug Therapy, Combination; Female; HIV Seronegativity; Humans; Leukoencep | 2018 |
Progressive multifocal leukoencephalopathy secondary to hepatitis C virus infection-related T-cell lymphopenia.
Topics: Aged; Antiviral Agents; Brain; Fatal Outcome; Hepatitis C; Humans; JC Virus; Leukoencephalopathy, Pr | 2019 |
Efficacy of mefloquine and mirtazapine on progressive multifocal leukoencephalopathy in a patient with peripheral T-cell lymphoma.
Topics: Aged; Drug Combinations; Humans; Leukoencephalopathy, Progressive Multifocal; Lymphoma, T-Cell, Peri | 2019 |
[A Patient with Progressive Multifocal Leukoencephalopathy Who Developed Bálint Syndrome Improved by Combination Therapy Using Mefloquine and Mirtazapine].
Topics: Apraxias; Brain; DNA, Viral; Humans; JC Virus; Leukoencephalopathy, Progressive Multifocal; Magnetic | 2019 |
Inflammatory Cerebellar PML with a CD4/CD8 Ratio of 2.9 Showed a Favorable Prognosis in a Patient with Rheumatoid Arthritis.
Topics: Aged; Antimalarials; Arthritis, Rheumatoid; Brain; CD4-CD8 Ratio; Cerebellum; Female; Humans; Immuno | 2019 |
Progressive multifocal leukoencephalopathy in a heart transplant recipient following rituximab therapy for antibody-mediated rejection.
Topics: Antibodies, Monoclonal, Murine-Derived; Cognition Disorders; Fatal Outcome; Graft Rejection; Heart F | 2013 |
HIV-associated progressive multifocal leukoencephalopathy: longitudinal study of JC virus non-coding control region rearrangements and host immunity.
Topics: Adrenal Cortex Hormones; Antiretroviral Therapy, Highly Active; Antiviral Agents; Coinfection; Fatal | 2013 |
Significant improvement following combination treatment with mefloquine and mirtazapine in a patient with progressive multifocal leukoencephalopathy after allogeneic peripheral blood stem cell transplantation.
Topics: Adult; Antiviral Agents; Brain; Drug Therapy, Combination; Female; Humans; Leukoencephalopathy, Prog | 2014 |
Progressive multifocal leukoencephalopathy complicating untreated chronic lymphatic leukemia: case report and review of the literature.
Topics: Cytarabine; Disease Progression; Female; Humans; JC Virus; Leukemia, Lymphocytic, Chronic, B-Cell; L | 2014 |
Progressive multifocal leukoencephalopathy in a patient with pre-clinical primary biliary cirrhosis.
Topics: Aged; Brain; Disease Progression; Female; Humans; JC Virus; Leukoencephalopathy, Progressive Multifo | 2014 |
Mirtazapine and mefloquine therapy for non-AIDS-related progressive multifocal leukoencephalopathy.
Topics: Adrenergic alpha-Antagonists; Aged; Drug Therapy, Combination; Humans; Leukoencephalopathy, Progress | 2014 |
Progressive multifocal leukoencephalopathy in common variable immunodeficiency: mitigated course under mirtazapine and mefloquine.
Topics: Antiviral Agents; Common Variable Immunodeficiency; DNA, Viral; Humans; JC Virus; Leukoencephalopath | 2015 |
Clearance of cerebrospinal fluid JCV DNA with mirtazapine in a patient with progressive multifocal leukoencephalopathy and sarcoidosis.
Topics: Aged; DNA, Viral; Female; Humans; Immunosuppressive Agents; JC Virus; Leukoencephalopathy, Progressi | 2016 |
Progressive multifocal leukoencephalopathy with bilateral middle cerebellar peduncle lesions confirmed by repeated CSF-JC virus tests and coexistence of JC virus granule cell neuronopathy. Report of a case.
Topics: Aged; Cerebellum; Cerebrospinal Fluid; Corneal Dystrophies, Hereditary; Diagnosis, Differential; DNA | 2016 |
JC virus granule cell neuronopathy in the setting of chronic lymphopenia treated with recombinant interleukin-7.
Topics: Aged; Ataxia; Chronic Disease; Hamartoma Syndrome, Multiple; Humans; Immunocompromised Host; Immunog | 2017 |
Progressive Multifocal Leukoencephalopathy after Ibrutinib Therapy for Chronic Lymphocytic Leukemia.
Topics: Adenine; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain; Disease | 2017 |
A case of progressive multifocal leukoencephalopathy with chronic renal failure, whose JC virus in cerebrospinal fluid disappeared after mefloquine-mirtazapine dual therapy.
Topics: Aged, 80 and over; Astrocytes; Brain; Cerebrospinal Fluid; Drug Therapy, Combination; Humans; Immuno | 2016 |
Mirtazapine in an HIV-1 infected patient with progressive multifocal leukoencephalopathy.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Antiretroviral Therapy, H | 2009 |
Progressive multifocal leukoencephalopathy - experimental options.
Topics: Humans; Leukoencephalopathy, Progressive Multifocal; Mianserin; Mirtazapine; Selective Serotonin Reu | 2009 |
[Progressive multifocal leukoencephalopathy in a patient with acute myeloid leukaemia after allogeneic hematopoietic-cell transplantation].
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Fatal Outcome; Graft vs H | 2011 |
Progressive multifocal leukoencephalopathy associated with isolated CD8+ T-lymphocyte deficiency mimicking tumefactive MS.
Topics: Aged; Brain; CD8-Positive T-Lymphocytes; Female; Humans; JC Virus; Leukoencephalopathy, Progressive | 2011 |
A case of progressive multifocal leukoencephalopathy in a patient with sarcoidosis.
Topics: Antimalarials; Antiviral Agents; Biopsy; Brain; Hemianopsia; Histamine H1 Antagonists; Histological | 2012 |
Early onset of natalizumab-related progressive multifocal leukoencephalopathy.
Topics: Antibodies, Monoclonal, Humanized; Glatiramer Acetate; Humans; Immunologic Factors; Immunosuppressiv | 2011 |
Mirtazapine and mefloquine therapy for progressive multifocal leukoencephalopathy in a patient infected with human immunodeficiency virus.
Topics: Cognition Disorders; Histamine H1 Antagonists; HIV Infections; Humans; JC Virus; Leukoencephalopathy | 2012 |
Longterm remission of more than 5 years in a patient with progressive multifocal leucoencephalopathy and sarcoidosis.
Topics: Anti-Inflammatory Agents; Antiviral Agents; Brain; Cidofovir; Cytosine; Female; Gait Disorders, Neur | 2012 |
Progressive multifocal leucoencephalopathy after autologous bone marrow transplantation: a treatment option.
Topics: Antidepressive Agents, Tricyclic; Antiviral Agents; Bone Marrow Transplantation; Cidofovir; Cytosine | 2011 |
Progressive multi-focal leukoencephalopathy as a rare lethal complication in untreated sarcoidosis.
Topics: Adrenergic alpha-Antagonists; Adult; DNA, Viral; Fatal Outcome; Humans; JC Virus; Leukoencephalopath | 2012 |
Favourable outcome of progressive multifocal leucoencephalopathy in two patients with dermatomyositis.
Topics: Adrenergic alpha-Antagonists; Cytarabine; Dermatomyositis; Female; Humans; Immunosuppressive Agents; | 2006 |
Progressive multifocal leucoencephalopathy in a patient with sarcoidosis--successful treatment with cidofovir and mirtazapine.
Topics: Antiviral Agents; Cidofovir; Cytosine; Drug Therapy, Combination; Female; Humans; Leukoencephalopath | 2007 |
Mirtazapine in progressive multifocal leukoencephalopathy associated with polycythemia vera.
Topics: Female; Humans; Leukoencephalopathy, Progressive Multifocal; Mianserin; Middle Aged; Mirtazapine; Po | 2007 |
5-HT2a inhibitors for progressive multifocal leukoencephalopathy: old drugs for an old disease.
Topics: Adult; Female; Humans; JC Virus; Leukoencephalopathy, Progressive Multifocal; Male; Mianserin; Middl | 2008 |